Connection

Michael Lilly to Cysteine Proteinase Inhibitors

Back to Details
This is a "connection" page, showing publications Michael Lilly has written about Cysteine Proteinase Inhibitors.
Michael Lilly
Connection Strength
0.397
Cysteine Proteinase Inhibitors
  1. Combination therapy of recurrent prostate cancer with the proteasome inhibitor bortezomib plus hormone blockade. Cancer Biol Ther. 2011 Jul 15; 12(2):119-24.
    View in: PubMed
    Score: 0.377
  2. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol Cancer. 2009 Aug 28; 8:68.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.